Menu Fermer

Articles sur Pfizer

Affichage de 1 à 20 de 113 articles

As of August 2022, COVID-19 vaccination rates in Black and Hispanic people exceeded those of white Americans nationally, but only for the initial shots. FatCamera/E+ via Getty Images

Low vaccine booster rates are now a key factor in COVID-19 deaths – and racial disparities in booster rates persist

Early on, public health messaging focused on the need for vaccines to combat COVID-19. But far less attention has been given to the role of boosters in preventing deaths and reducing inequities.
Global Justice campaigners in London stand by fake coffins to highlight global COVID-19 deaths. If pharma companies waived intellectual property rights, it would be easier for low- and middle-income countries to access COVID-19 vaccines. (AP Photo/Alastair Grant)

We still need a vaccine patent waiver, but not the one on offer at the World Trade Organization meeting

Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
The best way to stop new variants from arising is to increase the proportion of vaccinated individuals while maintaining infection prevention measures like wearing masks and social distancing. (Shutterstock)

Omicron: Vaccines remain the best defence against this COVID-19 variant and others

Even with a variant like Omicron that may be more transmissible than earlier variants, vaccines remain the most effective tool for protection against COVID-19 and for ending the pandemic.
The Lagos State government recently approved some private health facilities to administer COVID-19 vaccines in the state. Olukayode Jaiyeola/NurPhoto via Getty Images

How the private sector can boost COVID vaccination in Nigeria

Properly engaged and monitored, Nigeria’s private sector can do more in COVID vaccination exercise.

Les contributeurs les plus fréquents

Plus